Imsidolimab for the treatment of generalized pustular psoriasis, R.B. Warren et al.

preview_player
Показать описание
Author video for 'Imsidolimab, an Anti-IL-36 Receptor Monoclonal Antibody for the Treatment of Generalised Pustular Psoriasis: Results from the Phase 2 GALLOP Trial'

  1. British Journal of Dermatology
Рекомендации по теме
Imsidolimab for the 0:02:24

Imsidolimab for the treatment of generalized pustular psoriasis, R.B. Warren et al.

Pustular Psoriasis Treatment 0:00:53

Pustular Psoriasis Treatment Review

Results of phase 0:06:38

Results of phase III trial of lebrikizumab in moderate-to-severe AD at 52 weeks, A. Blauvelt et al.

Pustular psoriasis, distinct 0:12:43

Pustular psoriasis, distinct disease or part of psoriasis spectrum? | Hervé Bachelez, PhD | France

Pustular forms of 0:11:12

Pustular forms of psoriasis: What we have learnt from genetic studies | Francesca Capon, PhD | UK